Skip to content

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients With KCNQ1 or KCNH2 Mutation Without Long QT Interval in Rest ECG

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01745666
Acronym
QT long
Enrollment
130
Registered
2012-12-10
Start date
2012-05-31
Completion date
2018-05-31
Last updated
2016-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long QT Syndrome Type 1 or 2

Keywords

Long QT syndrome, stress tests

Brief summary

The aim of the study is to evaluate the best stress exam to unmask long QT in patient with KCNQ1 or KCNH2 mutation without long QT interval in rest electrocardiogram.

Detailed description

65 patients with KCNQ1 or KCNH2 mutation presenting QTc interval \<470msec and 65 patients without KCNQ1 or KCNH2 mutation presenting QTc interval \<470msec will be included. All patients will have the 2 tests: exercise test and epinephrine test, in one half day. At the end of the inclusions, two experts will examine examens results without knowing in which arm (mutated or not) the patient belongs.

Interventions

OTHEREpinephrine test

Epinephrine test : 1 hour after exercise test : epinephrine infusion during 20 minutes, and monitoring during 30 minutes after stop infusion with registering of electrocardiograms.

OTHERexercise test

Exercise test : Bruce protocol : exercise during 7 minutes, and rest during 6 minutes with registering of the electrocardiograms.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients with QTc\<470 msec, and with molecular analysis (KCNQ1 or KCNH2 genes) performed in order to include 65 patients with KCNQ1 or KCNH2 mutation and 65 patients without KCNQ1 or KCNH2 mutation (controls).

Exclusion criteria

* QTc interval \>470msec * Treatment interfering with cardiac repolarisation * Under 15 years old * Pregnant women * Contraindication to exercise or epinephrine tests * Patients without social coverage

Design outcomes

Primary

MeasureTime frameDescription
to evaluate the best stress exam (exercise test OR epinephrine test)to unmask long QT syndrome.day 1Exercise test and epinephrine test will be done at inclusion (day 1). The primary outcome of this study is to evaluate the best stress exam (exercise test versus epinephrine test), defined by a positive test to unmask long QT syndrome. Test is positive when QT interval lengthens 30 ms At the end of study inclusions, two reviewers will analyse, independently, electrocardiograms resulting from these tests to determine for each patient if a test was positive and which one. These reviewers will do this job without being informed of the patient status (mutated patient or not mutated patient (control)).

Secondary

MeasureTime frameDescription
to evaluate each test characteristicsDay 1Exercise test and epinephrine test will be done at inclusion (day 1). The secondary outcome is to evaluate each test (exercise test and epinephrine test) characteristics. At the end of study inclusions, two reviewers will independently analyse electrocardiograms resulting from these tests to evaluate their characteristics.

Countries

France

Contacts

Primary ContactVincent PROBST, PU-PH
vincent.probst@chu-nantes.fr+33 2 40 16 57 00
Backup ContactEric DELANNOY, PH

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026